نتائج البحث - Preet Paul Singh
- يعرض 1 - 16 نتائج من 16
-
1
-
2
Chemopreventive strategies in hepatocellular carcinoma حسب Siddharth Singh, Preet Paul Singh, Lewis R. Roberts, William Sánchez
منشور في 2013Revisão -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma حسب Wilson I. Gonsalves, S. Vincent Rajkumar, Vikas Gupta, William G. Morice, Michael Timm, Preet Paul Singh, Angela Dispenzieri, Francis K. Buadi, Martha Q. Lacy, Prashant Kapoor, Morie A. Gertz, Shaji Kumar
منشور في 2014Artigo -
11
Quantification of clonal circulating plasma cells in relapsed multiple myeloma حسب Wilson I. Gonsalves, William G. Morice, S. Vincent Rajkumar, Vinay Gupta, Michael Timm, Angela Dispenzieri, Francis K. Buadi, Martha Q. Lacy, Preet Paul Singh, Prashant Kapoor, Morie A. Gertz, Shaji Kumar
منشور في 2014Artigo -
12
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer T... حسب Preet Paul Singh, Qian Shi, Nathan R. Foster, Axel Grothey, Suresh Nair, Emily Chan, Anthony F. Shields, Richard M. Goldberg, Sharlene Gill, Morton S. Kahlenberg, Frank A. Sinicrope, Daniel J. Sargent, Steven R. Alberts
منشور في 2016Artigo -
13
Trends in survival of patients with primary plasma cell leukemia: a population-based analysis حسب Wilson I. Gonsalves, S. Vincent Rajkumar, Ronald S. Go, Angela Dispenzieri, Vinay Gupta, Preet Paul Singh, Francis K. Buadi, Martha Q. Lacy, Prashant Kapoor, David Dingli, John A. Lust, Steven R. Zeldenrust, Suzanne R. Hayman, Robert A. Kyle, Morie A. Gertz, Shaji Kumar
منشور في 2014Artigo -
14
Efficacy of VDT PACE‐like regimens in treatment of relapsed/refractory multiple myeloma حسب Arjun Lakshman, Preet Paul Singh, S. Vincent Rajkumar, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, David Dingli, Yi L. Hwa, Amie Fonder, Miriam Hobbs, Suzanne R. Hayman, Steven R. Zeldenrust, John A. Lust, Stephen J. Russell, Nelson Leung, Prashant Kapoor, Ronald S. Go, Yi Lin, Wilson I. Gonsalves, Taxiarchis Kourelis, Rahma Warsame, Robert A. Kyle, Shaji Kumar
منشور في 2017Artigo -
15
A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors حسب Sandip Pravin Patel, Megan Othus, Young Kwang Chae, Francis J. Giles, Donna E. Hansel, Preet Paul Singh, Annette Campbell Fontaine, Manisha H. Shah, Anup Kasi, Tareq Al Baghdadi, Marc Matrana, Zoran Gatalica, W. Michael Korn, Jourdain Hayward, Christine M. McLeod, Helen X. Chen, Elad Sharon, Edward Mayerson, Christopher W. Ryan, Melissa Plets, Charles D. Blanke, Razelle Kurzrock
منشور في 2020Artigo -
16
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study حسب Van K. Morris, Mohamed E. Salem, Halla Nimeiri, Syma Iqbal, Preet Paul Singh, Kristen K. Ciombor, Blasé N. Polite, Dustin A. Deming, Emily Chan, James L. Wade, Lianchun Xiao, Tanios Bekaii‐Saab, Luis M. Vence, Jorge Blando, Armeen Mahvash, Wai Chin Foo, Chimela Ohaji, Manolo Pasia, Gail L. Bland, Aki Ohinata, Jane E. Rogers, Amir Mehdizadeh, Kimberly C. Banks, Richard B. Lanman, Robert A. Wolff, Howard Streicher, James P. Allison, Padmanee Sharma, Cathy Eng
منشور في 2017Artigo
أدوات البحث:
موضوعات ذات صلة
Internal medicine
Medicine
Oncology
Cancer
Meta-analysis
Confidence interval
Gastroenterology
Multiple myeloma
Environmental health
Population
Clinical trial
Colorectal cancer
Hazard ratio
Immunotherapy
Adenocarcinoma
Adverse effect
Barrett's esophagus
Chemotherapy
Clinical endpoint
Cohort
Disease
Flow cytometry
Immune checkpoint
Immunology
Intensive care medicine
Nivolumab
Obesity
Observational study
Odds ratio
Phases of clinical research